Leukocytoclastic Vasculitis following the First Dose of the Elasomeran COVID-19 Vaccination

Our case highlights leukocytoclastic vasculitis as a potential side effect of the elasomeran COVID-19 vaccine. As the elasomeran vaccine becomes more widely available to the public, cutaneous reactions should be noted and looked for as potential side effects of the vaccine. Our patient had a history...

Descripción completa

Detalles Bibliográficos
Autores principales: Casale, Jarett J., Muse, Mikél E., Snow, Tara J., Gould, Karen P., Depcik-Smith, Natalie D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371881/
https://www.ncbi.nlm.nih.gov/pubmed/35968197
http://dx.doi.org/10.1155/2022/1469410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371881/
https://www.ncbi.nlm.nih.gov/pubmed/35968197
http://dx.doi.org/10.1155/2022/1469410

Ejemplares similares